Because PCD is a genetic condition, affected dogs are born with the disorder, although clinical signs may become more apparent as they grow. The inability of cilia to function normally can lead to the accumulation of mucus and pathogens within the respiratory system, causing recurring health problems throughout a dog's life. The condition is inherited and can be passed from parent dogs to their offspring, making genetic testing an important tool for breeders and owners.
Dogs with Primary Ciliary Dyskinesia often experience chronic or recurrent respiratory issues. Common signs may include persistent coughing, nasal discharge, frequent respiratory infections, difficulty breathing, exercise intolerance, and repeated episodes of pneumonia or bronchitis. Some dogs may also develop chronic ear infections due to impaired mucus drainage. In certain cases, reproductive problems may occur because cilia are involved in normal reproductive processes. The severity of symptoms can vary significantly among affected dogs.
The PCD DNA Health Test is designed to detect specific genetic mutations associated with Primary Ciliary Dyskinesia. Testing is typically performed using a simple cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine whether the dog carries the mutation linked to the condition. Since DNA remains unchanged throughout life, testing can be performed at any age, including in puppies before clinical signs develop.
Results are generally reported in one of three categories:
- Clear (Normal): The dog does not carry the tested PCD mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation but is typically not affected by the disease. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and is at increased risk of developing Primary Ciliary Dyskinesia and its associated clinical signs.
Genetic testing for PCD provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed breeding decisions that help reduce the incidence of the disorder while maintaining healthy genetic diversity within the breed. Avoiding the mating of two carrier dogs significantly decreases the likelihood of producing affected puppies.
For dog owners, knowledge of a dog's genetic status supports proactive healthcare planning. Dogs identified as at risk can benefit from regular veterinary evaluations, early diagnosis of respiratory problems, and appropriate management strategies designed to minimize complications and improve quality of life. While there is currently no cure for Primary Ciliary Dyskinesia, early recognition and supportive care can help manage symptoms and reduce the frequency of infections.
The Primary Ciliary Dyskinesia (PCD) Health Test is a valuable genetic screening tool that supports responsible breeding practices, promotes canine health, and helps reduce the impact of this inherited disorder in future generations. Through early detection and informed breeding decisions, breeders and owners can contribute to healthier dogs and improved long-term well-being.
